Company profile: LifeMine Therapeutics
1.1 - Company Overview
Company description
- Provider of genomics-, AI-, and synthetic biology-enabled drug discovery and development leveraging evolutionary insights from fungi. Offerings include Top-Down Drug Discovery and Avatar-Rx platforms, the LifeBank collection of 100,000 deep-sequenced wild-type fungi spanning over 25,000 species, pipeline programs such as LIFE-001 for transplantation and an anti-fungal portfolio, plus a GSK alliance to identify novel small-molecule leads for multiple disease areas.
Products and services
- LifeBank: A genome-scale, deep-sequenced collection of 100,000 wild-type fungi spanning over 25,000 species, supplying a vast biological space for digital drug discovery
- Avatar-RxTM: A computational platform that digitally analyzes fungal DNA for biosynthetic gene clusters to predict functions of small-molecule compounds, enabling rapid identification and development of new drug candidates
- Top-Down Drug DiscoveryTM: An evolution-guided approach that leverages fungal insights to pinpoint pharmacologically privileged drug leads by function rather than chemical structure
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LifeMine Therapeutics
G-CON
HQ: United States
Website
- Description: Provider of off-site, prefabricated cleanroom units (PODs) for pharmaceutical development and manufacturing, including design, construction, installation and qualification, enabling faster deployment versus traditional cleanroom infrastructure to address rapidly changing requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full G-CON company profile →
Immunologix
HQ: United States
Website
- Description: Provider of antibody-based therapeutics, producing human monoclonal antibodies targeting viral, bacterial, and tumor antigens, as well as human auto antigens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunologix company profile →
BioServ
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in upstream production and downstream processing of antibodies and other proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioServ company profile →
Standard BioTools
HQ: United States
Website
- Description: Provider of microfluidic-based chips and instrumentation for biological research as a biotech tools company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Standard BioTools company profile →
Ziylo
HQ: United Kingdom
Website
- Description: Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ziylo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LifeMine Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LifeMine Therapeutics
2.2 - Growth funds investing in similar companies to LifeMine Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LifeMine Therapeutics
4.2 - Public trading comparable groups for LifeMine Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →